echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Yuan Jing's research group published a research paper in eLife, revealing the molecules of Plasmodium cell morphology control...

    Yuan Jing's research group published a research paper in eLife, revealing the molecules of Plasmodium cell morphology control...

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 18, Yuan Jing's research group published a research paper
    titled Inner membrane complex proteomics reveals a palmitoylation regulation critical for intraerythrocytic development of malaria parasite in the journal eLife.


    Protozoa-Plasmodium parasites are the causative pathogens of malaria infectious diseases, causing hundreds of millions of people to be infected and hundreds of thousands of deaths
    each year.
    Malaria parasites with infectious capacity are cell-polar, and polar cell morphology is critical
    for the malaria parasite infection host.
    There is a unique membrane organelle (IMC) under the plasma membrane (PM) of the top-compound portal parasite represented by the malaria parasite, ---which plays a key role
    in the establishment and maintenance of polar cell morphology.
    The previous work of the research group revealed the physiological function and molecular mechanism
    of IMC regulation of the epidermal microtubule skeleton (The EMBO Journal, 2020) and Current Biology (2018).
    However, the protein components of IMC organelles and their localization mechanisms remain unknown
    .

    This work binds protein proximity labeling and protein mass spectrometry methods to reveal the protein components
    of the IMC organelles of Plasmodium.
    Combined with bioinformatics analysis, a class of IMC-related intracellular vesicle transporters
    was discovered.
    This work provides important fundamental data for further elucidation of the molecular mechanisms by which IMC arises and sustains
    .

    The work also found that there are extensive palmitoylation modifications in IMC proteins, suggesting that IMC proteins achieve organelle-specific localization
    through palmitoylation modifications.
    Further work found that palmitoyltransferase DHHC2 was specifically expressed in IMC
    .
    DHHC2 is modified by palmitoylation to control cell localization and function of specific IMC proteins including CDPK1 and GAP45, thereby regulating the cell morphology and red blood cell invasion
    of the malaria parasite.

    PhD student Qian Pengge, postdoctoral student Wang Xu and Associate Professor Zhong Legend are the first authors of this paper; Professor Yuan Jing is the corresponding author of this article, and Xiamen University is the first to complete it
    .
    The research was funded
    by the National Natural Science Foundation of China and the President's Fund of Xiamen University.

    Links to the full paper: https://elifesciences.
    org/articles/77447#content


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.